HOME >> BIOLOGY >> NEWS
Synthesized molecules studied as weapon to stop cell division in cancer cells

Blacksburg, Va., Aug. 23, 2004 -- An enzyme called Pin1, a gatekeeper of cell division, is present at high levels in a wide variety of cancer cells. Virginia Tech researchers who are designing small molecules to inhibit Pin1 are seeing promising results with a small U-shaped molecule.

Felicia Etzkorn, associate professor of chemistry, will report on her group's achievements in presentations at the 228th American Chemical Society (ACS) National Meeting in Philadelphia August 22-26.

Pin1 regulates the protein Cdc25, which initiates mitosis or cell division. Without Pin1, the cell enters programmed cell death -- which is good if it's a cancer cell.

"It makes sense to inhibit the Pin1 enzyme," said Etzkorn.

Protein shape determines biological function. Pin1 works by changing a peptide bond within Cdc25 from the trans shape (a flattened-Z shape) to the cis U-shape and back. This a simple change -- the swing of an arm one way or another to open or close the U results in a large conformation change in a protein.

The researchers synthesized cis and trans shaped inhibitors and introduced them into cancer cells. These inhibitors mimic part of the Cdc25 protein but do not bend to the will of Pin1. The research team discovered that cis inhibits the Pin1 enzyme's function 23 times better than trans. "This is very exciting because it tells us something fundamental about the mechanism.

The Etzkorn group tested the inhibitors in an ovarian cancer cell line. "That was the cell line that was available, but it should work for many cancers," Etzkorn said. "It would probably be particularly effective against breast cancer and prostate cancer. It seems to relate to secondary sexual characteristics."

However, a lot of work remains to be done to develop a drug, she cautions. "For instance, the inhibitor does not cross cell membranes. We can overcome that in the laboratory in order to study effectiveness, but have no
'"/>

Contact: Susan Trulove
strulove@vt.edu
540-231-5646
Virginia Tech
23-Aug-2004


Page: 1 2 3

Related biology news :

1. Human Metabolite Of Taxol Synthesized In The Laboratory
2. Tiny molecules have big potential as cancer drugs, Stanford researcher believes
3. Scientists reinvent DNA as template to produce organic molecules
4. Sweet success in targeting sugar molecules to cells in living animals
5. UC Riverside researcher takes snapshots of the movement of molecules in a billionth of a second
6. Scientists pinpoint molecules that generate synapses
7. Two molecules work together to aid transport of immune cells, UT Southwestern researchers find
8. Controlling biomolecules with magnetic tweezers
9. Water molecules clump more loosely than previously thought
10. Creating polymers that act like biomolecules
11. A new way to see DNA (and other tiny molecules)

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/11/2019)... ... October 11, 2019 , ... Advanced Clinical, a clinical ... Pavel Tyan has been appointed Therapeutic Lead for Oncology. Dr. Tyan brings a ... already strong scientific and delivery credentials previously offered at Advanced Clinical. , Dr. ...
(Date:10/8/2019)... ... October 08, 2019 , ... Enplug , a ... easier than ever for businesses and organizations to use their digital signage networks ... to count down to or count up from date-related milestones, while the Holidays ...
(Date:10/3/2019)... ... October 01, 2019 , ... The ... of chemicals, reagents, and medias and to be a more environmentally sustainable evolution ... culmination of years of experience and feedback from the original version we launched ...
Breaking Biology News(10 mins):
(Date:10/10/2019)... ... October 09, 2019 , ... ... Montgomery County middle school and high school students have improved neuro-cognitive executive skills ... techniques and physical fitness, and apply lifelong social/interpersonal, leadership, problem-solving and coping skills, ...
(Date:10/8/2019)... ... October 08, 2019 , ... Today, Massachusetts stem cell biotechnology company ... technology. Like the company’s precursor patent, approved in the U.S. in 2017, the ... stem cells. Asymmetrex now markets the technology in the U.S. as the AlphaSTEM ...
(Date:10/3/2019)... ... October 02, 2019 , ... eKare’s inSight® digital 3D ... Health Accelerator run by the East Midlands Academic Health Science Network (EMAHSN), the innovation ... technology in NHS by providing support to develop and deploy solutions to the most ...
(Date:9/24/2019)... ... September 24, 2019 , ... Drug resistance has been declared as one of ... MRSA becoming one of the most serious concerns. Hong Kong cannot be spared from ... MRSA (CA-MRSA), or a seven-fold of the figure in 2007 – the year the ...
Breaking Biology Technology:
Cached News: